DIEP 积压:不可能完成的任务?
本研究首次调查自体乳房再造等待名单,向31个单位发放问卷,发现至少2255例患者在等待名单上,按当前服务能力相当于2年5个月的积压,且40例女性在等待期间被诊断乳腺癌。作者建议增加手术室容量、优化整形外科医生工作计划并培训更多自体再造医生。
要点
- 至少2255例患者在自体乳房再造等待名单上,按当前服务能力相当于2年5个月积压。
- 40例女性在等待名单期间被诊断乳腺癌。
- COVID-19 影响显著,暴露了再造服务提供的全国性不平等和长等待名单。
核心结论
- COVID-19 影响显著,暴露了再造服务提供的全国性不平等和长等待名单。
- 作者建议增加手术室容量、优化整形外科医生工作计划以防止等待名单增长,并培训更多自体再造医生。
研究设计与样本
- 本研究为首次收集自体乳房再造等待名单数据的研究,向31个单位发放研究专用问卷。
主要发现
- 至少2255例患者在等待名单上,按当前服务能力相当于2年5个月的积压,不含新转诊。
- 40例女性据报道在等待名单期间被诊断乳腺癌。
临床怎么用
- 作者建议增加手术室容量。
- 作者建议优化整形外科医生工作计划以防止等待名单增长。
- 作者建议培训更多自体再造医生。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The outbreak of the coronavirus disease 2019 (COVID-19) pandemic caused global challenges, including the restriction of surgical options for women with breast cancer. Autologous reconstruction availability has still not returned to pre-COVID-19 levels. This study aimed to collect data about waiting lists for autologous breast reconstruction and is the first of its kind. A total of 31 units were approached and asked to complete a study specific questionnaire. In total, there are at least 2255 patients on a waiting list, which equates to a 2-year and 5-month backlog at the current level of provision, without the inclusion of new referrals. Alarmingly, 40 women reportedly developed breast cancer whilst on the waiting list. The impact of COVID-19 has been significant, revealing national inequity in reconstruction provision and long waiting lists. Recommendations include increasing theatre capacity, optimising plastic surgeons' job plans to prevent waiting lists from growing as well as training more surgeons in autologous reconstruction.
引用
- Abed H, Skillman J. DIEP backlog: Mission impossible? J Plast Reconstr Aesthet Surg. 2024. PMID: 39089212. doi:10.1016/j.bjps.2024.07.065
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。